UK markets closed

Koninklijke Philips N.V. (0LNG.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
19.65+0.26 (+1.37%)
At close: 06:09PM BST

Koninklijke Philips N.V.

Philips Center
Amstelplein 2
Amsterdam 1096 BC
Netherlands
31 20 597 7777
https://www.philips.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees71,519

Key executives

NameTitlePayExercisedYear born
Mr. Roy JakobsPres, CEO & Chairman of Management1.28MN/A1974
Dr. Paulus A. Stoffels M.D., Ph.D.Independent Vice Chairman of Supervisory Board & Sec.177.27kN/A1962
Mr. Abhijit BhattacharyaExec. VP, CFO & Member of the Board of Management1.13M485.44k1961
Mr. Marnix J. van GinnekenExec. VP, Chief ESG, Legal Officer & Member of the Board of Management831.35k244.75k1973
Mr. Willem AppeloExec. VP & COON/AN/A1965
Mr. Leandro MazzoniHead of Investor RelationsN/AN/AN/A
Ms. Daniela SeabrookExec. VP & Chief HR OfficerN/AN/A1973
Mr. Sean CarneyChief Design OfficerN/AN/AN/A
Mr. Andy HoExec. VP & Chief Market Leader of Philips Greater ChinaN/AN/A1961
Jan KimpenChief Medical OfficerN/AN/A1958
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Corporate governance

Koninklijke Philips N.V.’s ISS governance QualityScore as of 1 October 2023 is 3. The pillar scores are Audit: 1; Board: 1; Shareholder rights: 5; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.